Navigation Links
Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1

-1, the most treatment-resistant type of HCV, and the majority of patients (74%) had high baseline viral load ( > 800,000 IU/ml), a well-established negative predictive factor for SVR. Patients received daily injections of omega interferon (25 mcg) for up to 48 weeks. The endpoints for this clinical trial were early viral response (EVR), defined as a 2-log reduction in HCV RNA after 12 weeks of treatment, and SVR, defined as undetectable HCV RNA 24 weeks after the end of 48 weeks of treatment. Response rates are presented in the table below:


         HCV RNA Results               Omega IFN + RBV   Omega IFN Alone


    (LOQ= 50 IU/ml)                          N=67              N=35


    Early Viral Response (EVR)               84%               60%

    p= 0.014


    Sustained Viral Response(SVR)            36%               6%

    p= 0.001


With this study, Intarcia also took a step toward testing its hypothesis that maintaining continuous drug levels through daily administration of omega interferon may minimize side effects when compared to current interferon therapies. This study to date has shown that omega interferon is well tolerated with only two discontinuations due to adverse events. Results of this Phase 2 study suggest a favorable overall safety profile with no substantial safety issues being identified. Normalization of serum ALT, a marker of reduced liver inflammation, occurred in 100% of patients achieving SVR and no patients receiving omega interferon with ribavirin experienced relapse during 24 weeks of follow-up after completing 48 weeks of treatment.

Alice Leung, President and Chief Executive Officer of Intarcia stated, "We are developing omega interferon to improve the treatment of HCV by offering a more convenient, potentially safer and more efficacious therapy. Based on the data so far, we believe that a continuous release formulation of omega interferon has the potential to become an important therapy for HCV pat
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Intarcia Therapeutics Announces Presentation of Final Results From a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
9. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
10. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
11. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
Post Your Comments:
(Date:10/17/2014)... DUBLIN , Oct. 17, 2014 ... of the "Research and Development Prospect of ... offering. Based on the 2013 ... Chinese government policies about dialysis industry and the ... in-depth research about dialysis industry segmentations. Moreover, it ...
(Date:10/17/2014)... , Oct. 17, 2014 The ... Medical Technology Policy: The Green Park ... FDA, public and private payers, medical device and ... and other experts January 12, 2015 at its ... value of weight loss treatments.  Participants will discuss ...
(Date:10/17/2014)... , Oct. 17, 2014  China Biologic ... "Company"), a leading fully integrated plasma-based biopharmaceutical company ... that the Company has received approval from the ... commercial manufacturing of human prothrombin complex concentrate ("PCC") ... Shandong Taibang,s new coagulation factor production facility for ...
Breaking Medicine Technology:Research and Development Prospect of China Dialysis Market, 2014-2018 2Research and Development Prospect of China Dialysis Market, 2014-2018 3Green Park Collaborative to Discuss Comparative Effectiveness and Value of Weight Loss Treatments 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 3
... cells in bone marrow supply,leukemic cells with the ... is depleted by the cancer drug,asparaginase, MEMPHIS, Tenn., ... fails to help cure some children with acute,lymphoblastic ... the bone marrow counteract the effect of that ...
... in Gene Activity and Metabolic,Enzymes Show How Cells Respond ... a Key Player in the Daily Biochemical Routines that,Support ... at,St. Jude Children's Research Hospital have mapped out many ... a cell's,response to a shortage of a molecule called ...
Cached Medicine Technology:Leukemic Cells Find Safe Haven in Bone Marrow 2Leukemic Cells Find Safe Haven in Bone Marrow 3Study Shows Metabolic Strategy of Stressed Cell 2Study Shows Metabolic Strategy of Stressed Cell 3
(Date:10/20/2014)... Ohio (PRWEB) October 20, 2014 Principle ... years, takes pride in manufacturing top-of-the-line absorbent products. ... image of its most popular brand, Tranquility® Premium Protection ... created a new website, gave its packaging a new ... bring the brand message to the public. , The ...
(Date:10/20/2014)... October 20, 2014 Myoderm ... as Assistant Director of their CentralSource ... managing the innovative turnkey drug sourcing, distribution, and ... brings over 12 years of industry experience, in ... at the peak of their international success to ...
(Date:10/20/2014)... Portland, Oregon (PRWEB) October 20, 2014 Succeed ... 16% of local companies who participated in the Every ... Walk! is a public awareness project that encourages workers to ... the Summer Step 10,000 Program, which concluded at the end ... wide variety of cities and metro areas. Participating companies ...
(Date:10/20/2014)... OH (PRWEB) October 20, 2014 National Teen ... Chapter of the American Academy of Pediatrics (Ohio AAP, ... (NHTSA) in encouraging parents of teen drivers to talk to ... the road. , Motor vehicle crashes are the leading cause ... teen drivers involved in fatal crashes, and 859 (42%) of ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Unveiled at the ... Strategic Direction Scorecard conservatively estimates member hospital ROI on membership ... on dues, The Center provides $12.50 in value to member ... (Member Value – Member Dues)/Member Dues. , “This is ... this number and we think the methodology is really sound,” ...
Breaking Medicine News(10 mins):Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4
... , , , , ... ABT ) today announced financial results for the second quarter ended June ... Diluted earnings per share, excluding specified items, were $0.89, at the high end of ... Accepted Accounting Principles (GAAP) were $0.83. , Worldwide operational ...
... , , LOS ANGELES, July 15 ... get the best possible results with Face Lift Dentistry, a breakthrough ... health and optimal appearance of the mouth and face. , ... DDS, MAGD, long renowned for his high tech cosmetic and bite ...
... ... , ... July 15, 2009 -- HCC Medical Insurance Services is pleased to announce that ... as HCC Medical Insurance Services (HCCMIS), bringing increased financial security to the Company,s portfolio ...
... , LONDON, July 15 realbuzz.com is ... live a healthy, active life and,we,ve been looking at the most ... shorts and head off for your annual summer,holiday, take a peek ... work, and which ones are a total waste of your holiday-prepping,time! ...
... ... featured expert on searchjointpain.com, a new informational Web site devoted to all aspects of ... ... Sinatra , a board-certified cardiologist, nutritionist, and anti-aging specialist, is now a featured expert ...
... , , , SAN ... from the planned spinoff of Cardinal Health,s clinical and medical products businesses, ... principal amount of senior unsecured notes. The notes consist of the ... $250 million aggregate principal amount of 4.125% senior notes due ...
Cached Medicine News:Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 2Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 3Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 4Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 5Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 6Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 7Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 8Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 9Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 10Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 11Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 12Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 13Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 14Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 15Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 16Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 17Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 18Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 19Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 20Health News:Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009 21Health News:Los Angeles Cosmetic Dentist Sam Muslin's Breakthrough Procedure: Face Lift Dentistry 2Health News:Los Angeles Cosmetic Dentist Sam Muslin's Breakthrough Procedure: Face Lift Dentistry 3Health News:Los Angeles Cosmetic Dentist Sam Muslin's Breakthrough Procedure: Face Lift Dentistry 4Health News:MultiNational Underwriters Is Now HCC Medical Insurance Services 2Health News:realbuzz.com Top 10 Diets 2Health News:realbuzz.com Top 10 Diets 3Health News:realbuzz.com Top 10 Diets 4Health News:Board-Certified Cardiologist Dr. Stephen Sinatra Featured on Searchjointpain.com 2Health News:CareFusion Prices $1.4 Billion of Senior Notes 2
... -4C. 5.5 Cubic Ft. ... light. Manual push button ... Two shelves. In-door shelves ... thermostat. Magnetic gasket. Hermetically ...
Designed to meet the requirements of reagent grade water for routine analysis....
... Needs, Synergy systems produce ultrapure water from pre-treated ... 1.2 L/min to meet the basic needs of ... dual-wavelength UV lamp (185 nm and 254 nm) ... contaminants (< 5 ppb TOC when fed by ...
... mechanism for speed, stability and durability. ... display modes, multiple units of measure, ... auto print, and GLP/GMP/ISO output including ... clock. Touch-key calibration with external weights ...
Medicine Products: